| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $3.42B | +6.0% |
| Gross profit | $3.42B | — |
| Operating income | $0.48B | — |
| Net income | $0.20B | +21.2% |
| Gross margin | 100.0% | Net margin 5.8% |
| Segment | Revenue | Share |
|---|---|---|
| U.S.Dialysis With Intersegment | $2.94B | 86.1% |
| U.S.Dialysis And Related Lab Services | $2.92B | 85.5% |
| Other Operating Segments With Intersegment | $0.50B | 14.6% |
| All Other Segments | $0.49B | 14.5% |
| Item | Amount | % of revenue |
|---|---|---|
| Tax & other | $0.28B | 8.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
DECK ・ DE ・ DELL ・ DAL ・ DVN ・ DXCM ・ FANG ・ DLR ・ DG ・ DLTR ・ D ・ DPZ
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies